Bullous Dermatoses

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-03-25
Clinical Trial Update: Intradermal Tozinameran for Patients With Immune-mediated Dermatologic Diseases [Phase 4]
Phase 4 clinical trial update evaluating intradermal Tozinameran (COVID-19 vaccine) in patients with immune-mediated dermatologic diseases.